Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05722860 · ClinicalTrials.gov registry record · Phase 1
L-Citrulline and Endothelial Function
A Phase 1 study, sponsored by University of Oklahoma.
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
NCT05722860 is a Phase 1 study that has completed, run by University of Oklahoma. The registered enrollment target is 20 participants.
The verdict
NCT05722860, a Phase 1 study, has completed, sponsored by University of Oklahoma.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
Study Summary
The effect of L-Citrulline is well studied in relation to muscle strength, exhaustion, exercise performance, and endothelial function in health and disease. This study will extend current body of knowledge and will investigate the effect of L-Citrulline on brain vascular function.
Interventions
- DRUG L-Citrulline, capsule
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2024-01-03 |
| Est. Completion | 2024-12-28 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05722860
The ClinicalTrials.gov registry entry for NCT05722860 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which L-Citrulline, capsule is the first listed.
NCT05722860 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05722860 about?
NCT05722860 is a clinical study titled "L-Citrulline and Endothelial Function". The effect of L-Citrulline is well studied in relation to muscle strength, exhaustion, exercise performance, and endothelial function in health and disease. This study will extend current body of knowledge and will investigate the effect of L-Citrulline on brain vascular function.
What is the current status of trial NCT05722860?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2024-01-03. Estimated completion is 2024-12-28.
What interventions are being tested in trial NCT05722860?
The interventions under investigation include: L-Citrulline, capsule (DRUG).
Who is sponsoring clinical trial NCT05722860?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.